The monomer derivative of paeoniflorin inhibits macrophage pyroptosis via regulating TLR4/ NLRP3/ GSDMD signaling pathway in adjuvant arthritis rats

Int Immunopharmacol. 2021 Dec;101(Pt A):108169. doi: 10.1016/j.intimp.2021.108169. Epub 2021 Oct 1.

Abstract

Objective: This study was aimed to investigate the effect of monomer derivative of paeoniflorin (MDP) on macrophage pyroptosis mediated by TLR4/NLRP3/GSDMD signaling pathway in adjuvant arthritis (AA) rats.

Method: Wistar rats were divided into normal group, AA model group, MDP (50 mg/kg) group and MTX (0.5 mg/kg) group. The expression of TLR4, NLRP3 and GSDMD in macrophage were detected by immunofluorescence assay. The expression of TLR4 and the ratio of macrophage pyroptosis were analyzed by flow cytometry. Cell morphology was observed by scanning electron microscopy. The cytokine levels of IL-18 and IL-1β were detected by ELISA. The expressions of proteins related to macrophage pyroptosis were detected by western blot.

Results: MDP has a therapeutic effect on rats AA by reducing the secondary inflammation and improving pathological changes. The results of X-ray imaging and ultrasound images showed that MDP could inhibit bone erosion, soft tissue swelling, and joint space narrowing. Macrophage pyroptosis was found in secondary inflammation of AA rats. The expressions of TLR4, MyD88, NLRP3, Caspase-1, ASC, and GSDMD-N in macrophage were increased, the levels of IL-18 and IL-1β were enhanced, and the morphology of pyroptosis could be observed. MDP could inhibit macrophage polarization and macrophage pyroptosis, and down-regulated the cytokine levels of IL-18 and IL-1β in AA rats. MDP could regulate the M1/M2 ratio, decreased the ratio of macrophage pyroptosis and down-regulated the expressions of TLR4, MyD88, NLRP3, Caspase-1, ASC, and GSDMD-N in vivo and in vitro.

Conclusion: Abnormal activation of TLR4/NLRP3/GSDMD signaling pathway may be involved in macrophage pyroptosis in AA rats. The therapeutic effect of MDP on AA rats is related to the inhibition of macrophage pyroptosis by regulating the TLR4/NLRP3/GSDMD signaling pathway.

Keywords: Adjuvant arthritis; Macrophage pyroptosis; Monomer derivative of paeoniflorin; Rheumatoid arthritis; TLR4/NLRP3/GSDMD signaling pathway.

MeSH terms

  • Animals
  • Arthritis, Experimental / drug therapy*
  • Arthritis, Experimental / immunology
  • Arthritis, Experimental / pathology
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / pathology
  • Glucosides / chemistry
  • Glucosides / therapeutic use
  • Humans
  • Inflammasomes / drug effects
  • Inflammasomes / immunology
  • Inflammasomes / metabolism
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Male
  • Monoterpenes / chemistry
  • Monoterpenes / therapeutic use
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Phosphate-Binding Proteins / metabolism
  • Pore Forming Cytotoxic Proteins / metabolism
  • Pyroptosis / drug effects*
  • Pyroptosis / immunology
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Toll-Like Receptor 4 / metabolism

Substances

  • Glucosides
  • Gsdmd protein, rat
  • Inflammasomes
  • Monoterpenes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, rat
  • Phosphate-Binding Proteins
  • Pore Forming Cytotoxic Proteins
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • peoniflorin